Core Viewpoint - The announcement from 精优药业 (00858) details the resignation of Mr. 方林虎 as an independent non-executive director and chairman of the audit and remuneration committees, effective January 20, 2026, due to age and personal commitments [1] Board Changes - Mr. 方林虎 will step down from his roles, and Ms. 杨晓蓉 will be appointed as an independent non-executive director starting January 20, 2026 [1] - Following the resignation, the composition of the audit committee will change, with Ms. 金松 appointed as the new chair and Ms. 杨 as a new member [1] - The remuneration committee will also see Ms. 金松 as the new chair and Ms. 杨 as a new member after Mr. 方's departure [1] - In the nomination committee, Mr. 方 will no longer be a member, and Ms. 杨 will join as a new member [1]
精优药业：杨晓蓉获委任为独立非执行董事